Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariaelena Pierobon

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
JAMA Network Open|September 14, 2023
Geographical Variation in Social Determinants of Female Breast Cancer Mortality Across US CountiesTaylor Anderson, Dan Herrera, Franchesca Mireku, et al.
BMC Cancer|January 23, 2004
Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian regionGiorgio Zavagno, Gian Luca De Salvo, Dario Casara, et al.
Clinical Colorectal Cancer|September 10, 2009
Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.
Clinical Colorectal Cancer|May 9, 2009
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway BiomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.
Molecular Oncology|November 10, 2016
A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarrayElisa Pin, Steven Stratton, Claudio Belluco, et al.
Proteomics. Clinical Applications|February 14, 2015
Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicineElisa Baldelli, Eric B Haura, Lucio Crinò, et al.
Methods (San Diego, Calif.)|June 28, 2017
Protein network construction using reverse phase protein array dataRency S Varghese, Yiming Zuo, Yi Zhao, et al.
Scientific Reports|August 3, 2017
Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutationsGuanhua Rao, Mariaelena Pierobon, In-Kyu Kim, et al.
Clinical Proteomics|March 14, 2020
The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflowAllison L Hunt, Mariaelena Pierobon, Elisa Baldelli, et al.
Elife|September 7, 2022
Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesisÖzgün Le Roux, Nicole L K Pershing, Erin Kaltenbrun, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
JAMA Network Open|September 14, 2023
Geographical Variation in Social Determinants of Female Breast Cancer Mortality Across US CountiesTaylor Anderson, Dan Herrera, Franchesca Mireku, et al.
BMC Cancer|January 23, 2004
Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian regionGiorgio Zavagno, Gian Luca De Salvo, Dario Casara, et al.
Clinical Colorectal Cancer|September 10, 2009
Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.
Clinical Colorectal Cancer|May 9, 2009
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway BiomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.
Molecular Oncology|November 10, 2016
A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarrayElisa Pin, Steven Stratton, Claudio Belluco, et al.
Proteomics. Clinical Applications|February 14, 2015
Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicineElisa Baldelli, Eric B Haura, Lucio Crinò, et al.
Methods (San Diego, Calif.)|June 28, 2017
Protein network construction using reverse phase protein array dataRency S Varghese, Yiming Zuo, Yi Zhao, et al.
Scientific Reports|August 3, 2017
Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutationsGuanhua Rao, Mariaelena Pierobon, In-Kyu Kim, et al.
Clinical Proteomics|March 14, 2020
The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflowAllison L Hunt, Mariaelena Pierobon, Elisa Baldelli, et al.
Elife|September 7, 2022
Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesisÖzgün Le Roux, Nicole L K Pershing, Erin Kaltenbrun, et al.
Pageof 10